Academic Wits Research Outputs (All submissions)
Permanent URI for this collectionhttps://hdl.handle.net/10539/36827
Browse
38 results
Search Results
Item Bleed treatment with eptacog beta rFVIIa results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitorsA Dunn; Y Dargaud; y Abajas; M Carcao; E et al; Johnny MahlanguItem Adenoassociated virusbased gene therapy for hemophiliaaddressing the gapsW Miesbach; P Batty; P Chowdary; S Fong; Johnny Mahlangu; E et alItem Outcomes and management of invasive procedures in participants with hemophilia A post gene therapy a post hoc analysis of the GENEr81 phase III trialD Quon; J Wang; M Wang; D Pepperell; Johnny Mahlangu; E et alItem Efficacy safety and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr81 trialA Leavitt; Johnny Mahlangu; P Raheja; E Symington; D Quon; E et alItem The translational gap for gene therapies in low and middle income countries(WILEY-BLACKWELL) Kevin W Doxzen; Jenifer E Adair; Yris Maria Fonseca Bazzo; Daima Bukini; Johnny Mahlangu; E et alItem Diagnosis and treatment challenges in lower resource countries State of the art(WILEY-BLACKWELL) Johnny Mahlangu; S Diop; Michelle LavinItem Emicizumab is efficacious in people with Hemophilia A with comordities aged less than 50 years analysis of 4 phase III trials(WILEY-BLACKWELL) Víctor Jimenez-Yuste; Johannes Oldenburg; Eunice Tzeng; Elise Lim; Fabian Sanabria; Johnny MahlanguItem Long term outcomes with emicizumab in hemophilia A without inhibitors result from HAVEN 3 and 4 studies(WILEY-BLACKWELL) Johnny Mahlangu; Víctor Jimenez-Yuste; Giuliana Ventriglia; Markus Niggli; Simona Barlera; E et alItem Eptacog beta for the management of patients with hemophilia A and B with inhibitors A European perspective(WILEY-BLACKWELL) Wolfgang Miesbach; Manuel Carcao; Johnny Mahlangu; Yesim Dargaud; Victor Jimenez-Yuste; Cédric HermansItem FRONTIER 1 a partially randomized phase 2 study assessing the safetypharmacokinetics and pharmacodynamics of Mim8 a factor VIIIa mimetic(WILEY-BLACKWELL) S Lentz; P Chowdary; L Gil; F Lopez-Jaime; Johnny Mahlangu; E et al